Melanoma future or investigational therapies: Difference between revisions
Mahshid |
|||
| Line 14: | Line 14: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Dermatology]] | |||
[[Category:Surgery]] | |||
Latest revision as of 02:36, 27 November 2017
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
|
Melanoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Melanoma future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Melanoma future or investigational therapies |
|
Risk calculators and risk factors for Melanoma future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Future Techniques
In addition to identifying high-risk patients, researchers also want to identify high-risk lesions within a given patient. Many new technologies, such as optical coherence tomography (OCT), are being developed to accomplish this. OCT allows pathologists to view 3-D reconstructions of the skin and offers more resolution than past techniques could provide. In vivo confocal microscopy and fluorescently tagged antibodies are also proving to be valuable diagnostic tools.